Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Eli Lilly’s Jaypirca outpaces Imbruvica in landmark CLL head‑to‑head trial Eli Lilly’s Jaypirca beats Imbruvica in a head-to-head CLL trial. Explore why this breakthrough matters for BTK therapy and cancer care. bySrinathDecember 8, 2025